Health Vidya

ZEGERID for oral suspension and ZEGERID capsules are indicated in adults for the: •short-term treatment of active duodenal ulcer. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy. •short-term treatment (4 to 8 weeks) of active benign gastric ulcer. •treatment of heartburn and other symptoms associated with GERD for up to 4 weeks. •short-term treatment (4 to 8 weeks) of EE due to acid-mediated GERD which has been diagnosed by endoscopy in adults. oThe efficacy of ZEGERID used for longer than 8 weeks in patients with EE has not been established. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of EE or GERD symptoms (e.g., heartburn), additional 4 to 8-week courses of ZEGERID may be considered. •maintenance of healing of EE due to acid-mediated GERD. Controlled studies do not extend beyond 12 months. ZEGERID for oral suspension is indicated in adults for the: •reduction of risk of upper GI bleeding in critically ill adult patients.